TFF PHARMACEUTICALS, INC. SBIR Phase II Award, July 2023
A SBIR Phase II contract was awarded to TFF Pharmaceuticals in July, 2023 for $864,948.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Name
# Contributions
Last Contribution
Find more entities like TFF PHARMACEUTICALS, INC. SBIR Phase II Award, July 2023
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
